Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds

The synthesis of two different series of 3‐(thiadiazolyl)pyridine 1‐oxides containing 1,2,5‐ and 1,2,4‐thiadiazole moiety respectively is described. The potential muscarinic receptor binding together with the antioxidant properties of the new compounds were evaluated.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archiv der Pharmazie (Weinheim) 1999-06, Vol.332 (6), p.191-194
Hauptverfasser: Martinez, Ana, Alonso, Diana, Castro, Ana, Arán, Vicente J., Cardelús, Ignasi, Baños, Josep E., Badia, Albert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 194
container_issue 6
container_start_page 191
container_title Archiv der Pharmazie (Weinheim)
container_volume 332
creator Martinez, Ana
Alonso, Diana
Castro, Ana
Arán, Vicente J.
Cardelús, Ignasi
Baños, Josep E.
Badia, Albert
description The synthesis of two different series of 3‐(thiadiazolyl)pyridine 1‐oxides containing 1,2,5‐ and 1,2,4‐thiadiazole moiety respectively is described. The potential muscarinic receptor binding together with the antioxidant properties of the new compounds were evaluated.
doi_str_mv 10.1002/(SICI)1521-4184(19996)332:6<191::AID-ARDP191>3.0.CO;2-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69884265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69884265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4371-62a9b3306d92c7afd637bf5d82d0593dd78677f340d4e45fec5c3d486c59b9333</originalsourceid><addsrcrecordid>eNqFkdFu0zAUhiMEYmXwCigXCLUXKbZP4sQFgUoKo9KgVTu0iZsjN3Y2Q5oEOxUr4uFx1zKQQOLKcfSdX7_PFwSvKBlSQtiz_nKaTwc0YTSKaRb3qRCCDwDYiL-ggo5G4-kkGi8mc395CUMyzGfPWXRxJ-jdztwNegR4EnEGcBQ8cO4zIQQIS-4HR5SAEHGW9oIfy23dXWlnXChrFc6bTtedkVX4fuMKaU1tinChC912jQ1fm1qZ-vKGHHusuTZK1l04t02rbWe0C5syhKh_dmWkMvJ7U22rQbu1xo_pkEYzP6DDvFm3zaZW7mFwr5SV048O53Hw8e2bs_xddDo7mebj06iIIaX-BVKsAAhXghWpLBWHdFUmKmOKJAKUSjOepiXERMU6TkpdJAWoOONFIlYCAI6Dp_vc1jZfN9p1uDau0FUla91sHHKRZTHjiQfP92BhG-esLrG1Zi3tFinBnRjEnRjcLRl3S8YbMejFIPffFNGLwYMYBCSYz5DhhU9-fKiwWa21-iN3b8IDTw6A9IuvSivrwrjfXMYZgx32aY99M5Xe_lXvP-3-Xe7XLx8e7cON6_T1bbi0X5CnkCZ4_uEEM5ouyDKfYAw_ARVtxtg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69884265</pqid></control><display><type>article</type><title>Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Martinez, Ana ; Alonso, Diana ; Castro, Ana ; Arán, Vicente J. ; Cardelús, Ignasi ; Baños, Josep E. ; Badia, Albert</creator><creatorcontrib>Martinez, Ana ; Alonso, Diana ; Castro, Ana ; Arán, Vicente J. ; Cardelús, Ignasi ; Baños, Josep E. ; Badia, Albert</creatorcontrib><description>The synthesis of two different series of 3‐(thiadiazolyl)pyridine 1‐oxides containing 1,2,5‐ and 1,2,4‐thiadiazole moiety respectively is described. The potential muscarinic receptor binding together with the antioxidant properties of the new compounds were evaluated.</description><identifier>ISSN: 0365-6233</identifier><identifier>EISSN: 1521-4184</identifier><identifier>DOI: 10.1002/(SICI)1521-4184(19996)332:6&lt;191::AID-ARDP191&gt;3.0.CO;2-X</identifier><identifier>PMID: 10399487</identifier><identifier>CODEN: ARPMAS</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag GmbH</publisher><subject>Alzheimer Disease - drug therapy ; Alzheimer's disease ; antioxidants ; Antioxidants - chemical synthesis ; Antioxidants - metabolism ; Antioxidants - pharmacology ; Biological and medical sciences ; Cholinergic system ; Medical sciences ; muscarinic agonist ; Muscarinic Agonists - chemical synthesis ; Muscarinic Agonists - metabolism ; Muscarinic Agonists - pharmacology ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; pyridine N-oxides ; Receptors, Muscarinic - metabolism ; Thiadiazoles ; Thiadiazoles - chemical synthesis ; Thiadiazoles - metabolism ; Thiadiazoles - pharmacology</subject><ispartof>Archiv der Pharmazie (Weinheim), 1999-06, Vol.332 (6), p.191-194</ispartof><rights>1999 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291521-4184%2819996%29332%3A6%3C191%3A%3AAID-ARDP191%3E3.0.CO%3B2-X$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291521-4184%2819996%29332%3A6%3C191%3A%3AAID-ARDP191%3E3.0.CO%3B2-X$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1862237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10399487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez, Ana</creatorcontrib><creatorcontrib>Alonso, Diana</creatorcontrib><creatorcontrib>Castro, Ana</creatorcontrib><creatorcontrib>Arán, Vicente J.</creatorcontrib><creatorcontrib>Cardelús, Ignasi</creatorcontrib><creatorcontrib>Baños, Josep E.</creatorcontrib><creatorcontrib>Badia, Albert</creatorcontrib><title>Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds</title><title>Archiv der Pharmazie (Weinheim)</title><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><description>The synthesis of two different series of 3‐(thiadiazolyl)pyridine 1‐oxides containing 1,2,5‐ and 1,2,4‐thiadiazole moiety respectively is described. The potential muscarinic receptor binding together with the antioxidant properties of the new compounds were evaluated.</description><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer's disease</subject><subject>antioxidants</subject><subject>Antioxidants - chemical synthesis</subject><subject>Antioxidants - metabolism</subject><subject>Antioxidants - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cholinergic system</subject><subject>Medical sciences</subject><subject>muscarinic agonist</subject><subject>Muscarinic Agonists - chemical synthesis</subject><subject>Muscarinic Agonists - metabolism</subject><subject>Muscarinic Agonists - pharmacology</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>pyridine N-oxides</subject><subject>Receptors, Muscarinic - metabolism</subject><subject>Thiadiazoles</subject><subject>Thiadiazoles - chemical synthesis</subject><subject>Thiadiazoles - metabolism</subject><subject>Thiadiazoles - pharmacology</subject><issn>0365-6233</issn><issn>1521-4184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkdFu0zAUhiMEYmXwCigXCLUXKbZP4sQFgUoKo9KgVTu0iZsjN3Y2Q5oEOxUr4uFx1zKQQOLKcfSdX7_PFwSvKBlSQtiz_nKaTwc0YTSKaRb3qRCCDwDYiL-ggo5G4-kkGi8mc395CUMyzGfPWXRxJ-jdztwNegR4EnEGcBQ8cO4zIQQIS-4HR5SAEHGW9oIfy23dXWlnXChrFc6bTtedkVX4fuMKaU1tinChC912jQ1fm1qZ-vKGHHusuTZK1l04t02rbWe0C5syhKh_dmWkMvJ7U22rQbu1xo_pkEYzP6DDvFm3zaZW7mFwr5SV048O53Hw8e2bs_xddDo7mebj06iIIaX-BVKsAAhXghWpLBWHdFUmKmOKJAKUSjOepiXERMU6TkpdJAWoOONFIlYCAI6Dp_vc1jZfN9p1uDau0FUla91sHHKRZTHjiQfP92BhG-esLrG1Zi3tFinBnRjEnRjcLRl3S8YbMejFIPffFNGLwYMYBCSYz5DhhU9-fKiwWa21-iN3b8IDTw6A9IuvSivrwrjfXMYZgx32aY99M5Xe_lXvP-3-Xe7XLx8e7cON6_T1bbi0X5CnkCZ4_uEEM5ouyDKfYAw_ARVtxtg</recordid><startdate>199906</startdate><enddate>199906</enddate><creator>Martinez, Ana</creator><creator>Alonso, Diana</creator><creator>Castro, Ana</creator><creator>Arán, Vicente J.</creator><creator>Cardelús, Ignasi</creator><creator>Baños, Josep E.</creator><creator>Badia, Albert</creator><general>WILEY-VCH Verlag GmbH</general><general>WILEY‐VCH Verlag GmbH</general><general>Wiley-VCH</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199906</creationdate><title>Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds</title><author>Martinez, Ana ; Alonso, Diana ; Castro, Ana ; Arán, Vicente J. ; Cardelús, Ignasi ; Baños, Josep E. ; Badia, Albert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4371-62a9b3306d92c7afd637bf5d82d0593dd78677f340d4e45fec5c3d486c59b9333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer's disease</topic><topic>antioxidants</topic><topic>Antioxidants - chemical synthesis</topic><topic>Antioxidants - metabolism</topic><topic>Antioxidants - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cholinergic system</topic><topic>Medical sciences</topic><topic>muscarinic agonist</topic><topic>Muscarinic Agonists - chemical synthesis</topic><topic>Muscarinic Agonists - metabolism</topic><topic>Muscarinic Agonists - pharmacology</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>pyridine N-oxides</topic><topic>Receptors, Muscarinic - metabolism</topic><topic>Thiadiazoles</topic><topic>Thiadiazoles - chemical synthesis</topic><topic>Thiadiazoles - metabolism</topic><topic>Thiadiazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martinez, Ana</creatorcontrib><creatorcontrib>Alonso, Diana</creatorcontrib><creatorcontrib>Castro, Ana</creatorcontrib><creatorcontrib>Arán, Vicente J.</creatorcontrib><creatorcontrib>Cardelús, Ignasi</creatorcontrib><creatorcontrib>Baños, Josep E.</creatorcontrib><creatorcontrib>Badia, Albert</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Archiv der Pharmazie (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez, Ana</au><au>Alonso, Diana</au><au>Castro, Ana</au><au>Arán, Vicente J.</au><au>Cardelús, Ignasi</au><au>Baños, Josep E.</au><au>Badia, Albert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds</atitle><jtitle>Archiv der Pharmazie (Weinheim)</jtitle><addtitle>Arch. Pharm. Pharm. Med. Chem</addtitle><date>1999-06</date><risdate>1999</risdate><volume>332</volume><issue>6</issue><spage>191</spage><epage>194</epage><pages>191-194</pages><issn>0365-6233</issn><eissn>1521-4184</eissn><coden>ARPMAS</coden><abstract>The synthesis of two different series of 3‐(thiadiazolyl)pyridine 1‐oxides containing 1,2,5‐ and 1,2,4‐thiadiazole moiety respectively is described. The potential muscarinic receptor binding together with the antioxidant properties of the new compounds were evaluated.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag GmbH</pub><pmid>10399487</pmid><doi>10.1002/(SICI)1521-4184(19996)332:6&lt;191::AID-ARDP191&gt;3.0.CO;2-X</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0365-6233
ispartof Archiv der Pharmazie (Weinheim), 1999-06, Vol.332 (6), p.191-194
issn 0365-6233
1521-4184
language eng
recordid cdi_proquest_miscellaneous_69884265
source MEDLINE; Access via Wiley Online Library
subjects Alzheimer Disease - drug therapy
Alzheimer's disease
antioxidants
Antioxidants - chemical synthesis
Antioxidants - metabolism
Antioxidants - pharmacology
Biological and medical sciences
Cholinergic system
Medical sciences
muscarinic agonist
Muscarinic Agonists - chemical synthesis
Muscarinic Agonists - metabolism
Muscarinic Agonists - pharmacology
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
pyridine N-oxides
Receptors, Muscarinic - metabolism
Thiadiazoles
Thiadiazoles - chemical synthesis
Thiadiazoles - metabolism
Thiadiazoles - pharmacology
title Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T19%3A36%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Potential%20Muscarinic%20Receptor%20Binding%20and%20Antioxidant%20Properties%20of%203-(Thiadiazolyl)pyridine%201-Oxide%20Compounds&rft.jtitle=Archiv%20der%20Pharmazie%20(Weinheim)&rft.au=Martinez,%20Ana&rft.date=1999-06&rft.volume=332&rft.issue=6&rft.spage=191&rft.epage=194&rft.pages=191-194&rft.issn=0365-6233&rft.eissn=1521-4184&rft.coden=ARPMAS&rft_id=info:doi/10.1002/(SICI)1521-4184(19996)332:6%3C191::AID-ARDP191%3E3.0.CO;2-X&rft_dat=%3Cproquest_cross%3E69884265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69884265&rft_id=info:pmid/10399487&rfr_iscdi=true